Published Articles

• Project Briefs
• Case Studies
• Literature
• White Papers
• Published Articles
• Presentations

Informative pieces written by Tunnell Consulting subject matter experts that have been published in leading
industry publications.

• 

  Quality by Design and Compliance Readiness: How Will Implementing Quality by Design Strategies Affect Your Compliance Status?
  Chester A Meyers Ph.D.
  Debra Weigl
  BioPharm International - January 15, 2010

• 

  QbD and GMPs: How the Convergence of Science and Compliance Will Change the Way We Work
  Chester A Meyers Ph.D.
  Debra Weigl
  BioPharm International - November 02, 2009

• 

  How to Shift from Reactive Compliance to Strategic Quality Management
  Michael M Breggar DPM
  BioPharm International - July 01, 2009

• 

  When Less is More: Lean Can Help Reduce Costs and Improve Compliance Simultaneously
  Chris S Driscoll
  BioPharm International - May 01, 2009

• 

  Quality by Design: Four Years and Three Myths Later
  Ron D Snee Ph.D.
  Pharmaceutical Processing - February 01, 2009

• 

  Executives & Improvement
  Ron D Snee Ph.D.
  Contract Pharmaceutical - January 29, 2009

• 

  Serving Two Masters: Reconciling EMEA/GAMP 5 and FDA/cGMP Phase 1
  Sandy Weinberg
  Siddharth J Advant Ph.D.
  BioPharm International - January 01, 2009

• 

  Make Data Matter: A Five-Pronged Approach to Analyze Process Data
  Ron Snee Ph.D.
  Quality Progress - December 01, 2008

• 

  The Company at the Crossroads, Part 2: Build or Buy?
  Siddharth J Advant Ph.D.
  James Bonine
  Conrad J Heilman Jr., Ph.D.
  BioPharm International - November 01, 2008

• 

  Get Your Motor Running
  Raymond Rogers
  Pharmaceutical Processing - November 03, 2008

• 

  Putting It All Together
  Ron D Snee Ph.D.
  Edgar C Gardner
  Quality Progress - October 01, 2008

• 

  The Myths of Operational Excellence
  Christopher S Driscoll
  Contract Pharma - October 01, 2008

• 

  Lessons from Heparin
  Agnes Shanley
  Pharmaceutical Manufacturing - September 02, 2008

• 

  The Company at the Crossroads, Part 1: To Commercialize or Not?
  Joseph J Villafranca Ph.D.
  Conrad J Heilman Jr., Ph.D.
  Siddharth J Advant Ph.D.
  BioPharm International - September 01, 2008

• 

  Coming to a Biotech Near You: Quality by Design, Part 2: Design Space in Development and Manufacturing
  Conrad J Heilman Jr., Ph.D.
  Jason J Kamm
  BioPharm International - July 01, 2008

• 

  Coming to a Biotech Near You: Quality by Design, Part 1: Its Applicability in Biopharmaceuticals
  Conrad J Heilman Jr., Ph.D.
  BioPharm International - May 01, 2008

• 

  How to Ensure Smooth Technology Transfer
  Siddharth J Advant Ph.D.
  BioPharm International - March 01, 2008

• 

  How to Avoid Becoming a Biotech Zombie, Part 3
  Joseph J Villafranca Ph.D.
  James E Bonine
  BioPharm International - March 03, 2008

• 

  Quality by Design: Shortening the Path to Acceptance
  Chester A Meyers Ph.D.
  Ron D Snee Ph.D.
  Jason J Kamm
  Philippe Cini Ph.D.
  Pharmaceutical Processing - February 01, 2008

• 

  How to Avoid Becoming a Biotech Zombie, Part 2
  Carmen Medina
  BioPharm International - February 01, 2008

• 

  International Technology Transfer - By Design
  William Reilly Jr.
  Chester A Meyers Ph.D.
  Ron D Snee Ph.D.
  International Pharmaceutical Industry - January 01, 2008

• 

  Preparing for Your First IND Submission: The Devil is in the Details
  Conrad J Heilman Jr., Ph.D.
  Joseph J Villafranca Ph.D.
  BioPharm International - January 01, 2008

• 

  How to Avoid Becoming A Biotech Zombie, Part 1
  Carmen Medina
  Joseph J Villafranca Ph.D.
  BioPharm International - January 01, 2008

Printer Friendly